Kyndryl Slumps Ahead of Return to Organic Growth -- Market Talk
Dow Jones
Aug 06
1310 ET - Kyndryl dives after a tough F1Q for revenue, but the weakness looks like a good buying opportunity for bullish analysts at Oppenheimer who expect the company to return to organic growth next quarter. Constant currency revenue was down 2.6% from signing delays at a handful of large focus accounts, the analysts say. But management believes those delays are esoteric rather than related to broader macro problems, and that organic growth should return in F2Q, the analysts say. Management also maintained FY26 guidance that calls for constant currency revenue growth of 1%, they say. Kyndryl tumbles 21% at $29.14. (dean.seal@wsj.com)
(END) Dow Jones Newswires
August 05, 2025 13:10 ET (17:10 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.